Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study

MLA

Piraccini, B. M., et al. Real-Life Effectiveness and Safety of Baricitinib in Patients with Severe Alopecia Areata: A 24-Week Italian Study. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1479532071&authtype=sso&custid=ns315887.

APA

Piraccini, B. M., Pampaloni, F., Cedirian, S., Quadrelli, F., Bruni, F., Rapparini, L., Caro, G., Acri, M. C., Ala, L., Rossi, A., Pellacani, G., Lacarrubba, F., Micali, G., Dall’Oglio, F., Vastarella, M., Cantelli, M., Nappa, P., Diluvio, L., Bianchi, L., … Dini V. (2024). Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study.

Chicago

Piraccini, B. M., F. Pampaloni, S. Cedirian, F. Quadrelli, F. Bruni, L. Rapparini, G. Caro, et al. 2024. “Real-Life Effectiveness and Safety of Baricitinib in Patients with Severe Alopecia Areata: A 24-Week Italian Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1479532071&authtype=sso&custid=ns315887.